Zobrazeno 1 - 10
of 103
pro vyhledávání: '"W, Kortlandt"'
Publikováno v:
Transfusion and Apheresis Science. 48:207-211
Background and objectives Transfusion of autologous whole blood is one available method to reduce the need for allogenic blood transfusion. The aim of the present study was to investigate the quality of shed blood collected in a new intraoperative au
Autor:
H. J. A. Collette, Yolanda van der Graaf, Wim J. M. J. Gorgels, D. Willem Erkelens, Jan-Dirk Banga, W. Kortlandt, Paul Hjemdahl
Publikováno v:
American Journal of Epidemiology. 142:1157-1164
Increased plasma levels of beta-thromboglobulin, a platelet activation marker, are observed in coronary artery disease. Urinary albumin excretion, a marker of endothelial cell perturbation, is related to cardiovascular disease in diabetes. To test th
Publikováno v:
Pediatric Exercise Science. 6:128-139
A 3-year controlled intervention was used to study the influence of physical activity on the plasma lipid and apoprotein profile of 10-year-old Dutch schoolchildren. Twice-a-year measurements were taken of height, weight, body composition (skinfolds)
Autor:
W. Kortlandt, J. A. Gimpel, Bonno N. Bouma, P.F.C.C.M. Duif, H. J. M. Van Rijn, Bas C. Leerink
Publikováno v:
Thrombosis and Haemostasis. 68:185-188
SummaryLipoprotein(a) [Lp(a)] is recognized as an independent risk factor for atherosclerosis. Lp(a) consists of a LDL-like moiety with an additional glycoprotein, apo(a), linked to apolipoprotein B-100. Apo(a) has a high homology with plasminogen (P
Publikováno v:
Clinical chemistry. 46(1)
With the trend toward laboratory and workstation consolidation, more studies are necessary to evaluate instrumentation, solutions for coping with workflow and test diversity, and opportunities for increasing the overall efficiency of laboratory testi
Autor:
Tjerk W.A. de Bruin, Manuel Castro Cabezas, Hans Jansen, D. Willem Erkelens, L. A. W. Kock, Margreet Van Linde-Sibenius Trip, W. Kortlandt
Publikováno v:
Metabolism: clinical and experimental. 42(4)
It is unknown whether the clearance of atherogenic chylomicron remnants and the postprandial lipoprotein metabolism in general can be improved by 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in subjects with familial combined
Publikováno v:
Thrombosis and haemostasis. 68(2)
Lipoprotein(a) [Lp(a)] is recognized as an independent risk factor for atherosclerosis. Lp(a) consists of a LDL-like moiety with an additional glycoprotein, apo(a), linked to apolipoprotein B-100. Apo(a) has a high homology with plasminogen (Pg). In
Publikováno v:
Diabetologia. 35(3)
Hyperglycaemia in diabetes mellitus is responsible for the process of non-enzymatic glycosylation of different proteins. Since we did not find elevated glycated apolipoprotein B levels in diabetic patients, an altered glycated apolipoprotein B metabo
Autor:
Hendrik A. Koomans, W. Kortlandt, E. van Garderen, D.W. Erkelens, A. van Tol, L.H.J.C. Danse, J. A. Joles, Nel Willekes-Koolschijn, M.M. Geelhoed-Mieras
Publikováno v:
Atherosclerosis. 88(1)
Plasma lipoprotein distribution and apolipoprotein concentrations, as well as kidney function and histopathology of heart, aorta, liver and kidney were investigated in 1-year-old Nagase analbuminemic rats (NAR) and control Sprague-Dawley rats (SDR).
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 193(3)
Apolipoprotein (Apo) B100 is the obligatory structural protein of low and very low density lipoproteins. We studied the appearance of a kallikrein-induced proteolytic fragment of Apo B100, identified by sodium dodecyl sulphate (SDS)-polyacrylamide el